DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Hyams JS, Griffiths A, Markowitz J. et al.
Safety and efficacy of adalimumab for moderate to severe Crohnʼs disease in children.
Gastroenterology 2012;
143: 365-374
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.